$FONR
FONAR CORP Stock $fonr

$fonr Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000035501917000011 Filed on May 10, 2017

Income Statement

Concept	2017 Q1	2016 Q2	2016 Q1
Revenue	$218.0K	$18.77M	$546.0K
YoY Change	-60.07%	11.21%	8.76%
Cost Of Revenue	$364.0K	$9.580M	$263.0K
YoY Change	38.4%	-1.24%	-25.28%
Gross Profit	-$146.0K	$9.190M	$283.0K
YoY Change	-151.59%	27.99%	88.67%
Gross Profit Margin	-66.97%	48.96%	51.83%
Selling, General & Admin	$4.483M	$6.380M	$4.063M
YoY Change	10.34%	93.92%	9.63%
% of Gross Profit		69.42%	1435.69%
Research & Development	$332.0K	$390.0K	$395.0K
YoY Change	-15.95%	-44.29%	9.72%
% of Gross Profit		4.24%	139.58%
Depreciation & Amortization	$868.0K	$790.0K	$830.0K
YoY Change	4.58%	-9.2%	-6.64%
% of Gross Profit		8.6%	293.29%
Operating Expenses	$4.815M	$6.770M	$4.458M
YoY Change	8.01%	70.1%	9.64%
Operating Profit	-$4.961M	$2.420M	-$4.175M
YoY Change	18.83%	-24.38%	6.61%
Interest Expense	-$69.00K	$210.0K	-$127.0K
YoY Change	-45.67%	-310.0%	-24.85%
% of Operating Profit		8.68%
Other Income/Expense, Net	$2.000K	$190.0K
YoY Change		-52.5%
Pretax Income	$5.982M	$2.820M	$4.026M
YoY Change	48.58%	-19.2%	57.94%
Income Tax	$1.140M	-$4.520M	-$145.0K
% Of Pretax Income	19.06%	-160.28%	-3.6%
Net Earnings	$5.900M	$6.360M	$3.005M
YoY Change	96.34%	2.58%	48.84%
Net Earnings / Revenue	2706.42%	33.88%	550.37%
Basic Earnings Per Share	$0.96		$0.50
Diluted Earnings Per Share	$883.2K	$969.5K	$458.8K
COMMON SHARES
Basic Shares Outstanding	6.166M shares		6.050M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q1	2016 Q2	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.800M	$8.500M	$13.10M
YoY Change	-40.46%	-9.57%	67.95%
Cash & Equivalents	$7.750M	$8.528M	$13.15M
Short-Term Investments
Other Short-Term Assets	$1.100M	$800.0K	$800.0K
YoY Change	37.5%	-11.11%	-11.11%
Inventory	$3.300M	$2.100M	$2.500M
Prepaid Expenses
Receivables	$38.70M	$34.20M	$34.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$50.84M	$45.56M	$50.91M
YoY Change	-0.13%	4.44%	18.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.29M	$14.51M	$11.88M
YoY Change	28.75%	12.49%	-11.72%
Goodwill	$3.322M	$3.322M	$1.767M
YoY Change	88.0%	88.0%	0.0%
Intangibles	$6.920M	$7.719M	$8.066M
YoY Change	-14.21%	-13.75%	-16.44%
Long-Term Investments
YoY Change
Other Assets	$15.50M	$13.80M	$9.400M
YoY Change	64.89%	48.39%	42.42%
Total Long-Term Assets	$40.96M	$39.34M	$31.09M
YoY Change	31.74%	19.65%	-1.06%
TOTAL ASSETS
Total Short-Term Assets	$50.84M	$45.56M	$50.91M
Total Long-Term Assets	$40.96M	$39.34M	$31.09M
Total Assets	$91.80M	$84.90M	$82.00M
YoY Change	11.95%	10.98%	10.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.183M	$1.254M	$1.345M
YoY Change	-12.04%	-29.62%	-41.62%
Accrued Expenses	$6.500M	$9.300M	$7.200M
YoY Change	-9.72%	27.4%	-10.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$700.0K	$4.507M	$2.500M
YoY Change	-72.0%	80.28%	-13.79%
Total Short-Term Liabilities	$14.45M	$20.61M	$18.58M
YoY Change	-22.23%	9.69%	-8.3%
LONG-TERM LIABILITIES
Long-Term Debt	$300.0K	$2.100M	$3.900M
YoY Change	-92.31%	-63.16%	-38.1%
Other Long-Term Liabilities	$1.100M	$1.000M	$1.000M
YoY Change	10.0%	42.86%	150.0%
Total Long-Term Liabilities	$1.948M	$3.498M	$5.328M
YoY Change	-63.44%	-49.42%	-26.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.45M	$20.61M	$18.58M
Total Long-Term Liabilities	$1.948M	$3.498M	$5.328M
Total Liabilities	$16.40M	$24.11M	$23.91M
YoY Change	-31.41%	-6.21%	-13.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$106.9M	-$120.6M
YoY Change		-11.53%
Common Stock	$176.8M	$173.7M	$175.4M
YoY Change	0.75%	-0.99%	0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)	-$675.0K	-$675.0K	-$675.0K
YoY Change	0.0%	0.0%	-200.0%
Treasury Stock Shares
Shareholders Equity	$69.20M	$60.78M	$47.80M
YoY Change
Total Liabilities & Shareholders Equity	$91.82M	$84.89M	$82.01M
YoY Change	11.96%	10.98%	10.02%

Cashflow Statement

Concept	2017 Q1	2016 Q2	2016 Q1
OPERATING ACTIVITIES
Net Income	$5.900M	$6.360M	$3.005M
YoY Change	96.34%	2.58%	48.84%
Depreciation, Depletion And Amortization	$868.0K	$790.0K	$830.0K
YoY Change	4.58%	-9.2%	-6.64%
Cash From Operating Activities	$2.770M	$6.320M	$2.390M
YoY Change	15.9%	33.9%	-9.47%
INVESTING ACTIVITIES
Capital Expenditures	-$300.0K	-$230.0K	-$150.0K
YoY Change	100.0%	475.0%	36.36%
Acquisitions
YoY Change
Other Investing Activities		-$4.220M
YoY Change
Cash From Investing Activities	-$300.0K	-$4.450M	-$150.0K
YoY Change	100.0%	11025.0%	36.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.420M	-6.490M	-2.040M
YoY Change	18.63%	111.4%	-67.97%
NET CHANGE
Cash From Operating Activities	2.770M	6.320M	2.390M
Cash From Investing Activities	-300.0K	-4.450M	-150.0K
Cash From Financing Activities	-2.420M	-6.490M	-2.040M
Net Change In Cash	50.00K	-4.620M	200.0K
YoY Change	-75.0%	-386.96%	-105.21%
FREE CASH FLOW
Cash From Operating Activities	$2.770M	$6.320M	$2.390M
Capital Expenditures	-$300.0K	-$230.0K	-$150.0K
Free Cash Flow	$3.070M	$6.550M	$2.540M
YoY Change	20.87%	37.61%	-7.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	7750000	usd
CY2016Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8528000	usd
CY2017Q1	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2670000	usd
CY2016Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2074000	usd
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1059000	usd
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	759000	usd
CY2017Q1	us-gaap	Assets Current AssetsCurrent	50839000	usd
CY2016Q2	us-gaap	Assets Current AssetsCurrent	45560000	usd
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15292000	usd
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14513000	usd
CY2017Q1	us-gaap	Other Assets OtherAssets	509000	usd
CY2016Q2	us-gaap	Other Assets OtherAssets	732000	usd
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	727000	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2448000	usd
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1183000	usd
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1254000	usd
CY2017Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7483000	usd
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10827000	usd
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3987000	usd
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4679000	usd
CY2017Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1018000	usd
CY2016Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1199000	usd
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14451000	usd
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20614000	usd
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	348000	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2059000	usd
CY2017Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1948000	usd
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3498000	usd
CY2017Q1	us-gaap	Liabilities Liabilities	16399000	usd
CY2016Q2	us-gaap	Liabilities Liabilities	24112000	usd
CY2017Q1	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	28000	usd
CY2016Q2	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent		usd
CY2017Q1	us-gaap	Goodwill Goodwill	3322000	usd
CY2016Q2	us-gaap	Goodwill Goodwill	3322000	usd
CY2017Q1	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	228000	usd
CY2016Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	245000	usd
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	20000	usd
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1103000	usd
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	780000	usd
CY2017Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	768000	usd
CY2016Q1	us-gaap	Maintenance Revenue MaintenanceRevenue	2406000	usd
	us-gaap	Maintenance Revenue MaintenanceRevenue	7074000	usd
	us-gaap	Maintenance Revenue MaintenanceRevenue	6970000	usd
CY2017Q1	us-gaap	Maintenance Revenue MaintenanceRevenue	2366000	usd
CY2016Q1	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	27000	usd
	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	83000	usd
	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	83000	usd
CY2017Q1	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	27000	usd
CY2016Q1	us-gaap	Management Fees Revenue ManagementFeesRevenue	9394000	usd
	us-gaap	Management Fees Revenue ManagementFeesRevenue	28216000	usd
	us-gaap	Management Fees Revenue ManagementFeesRevenue	27180000	usd
CY2017Q1	us-gaap	Management Fees Revenue ManagementFeesRevenue	9592000	usd
CY2016Q1	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	1907000	usd
	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	6020000	usd
	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	5598000	usd
CY2017Q1	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	2206000	usd
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	263000	usd
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	543000	usd
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	939000	usd
CY2017Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	364000	usd
CY2016Q1	us-gaap	Maintenance Costs MaintenanceCosts	552000	usd
	us-gaap	Maintenance Costs MaintenanceCosts	2168000	usd
	us-gaap	Maintenance Costs MaintenanceCosts	1542000	usd
CY2017Q1	us-gaap	Maintenance Costs MaintenanceCosts	829000	usd
CY2016Q1	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	6000	usd
	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	25000	usd
	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	18000	usd
CY2017Q1	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	10000	usd
CY2016Q1	us-gaap	Service Management Costs ServiceManagementCosts	5649000	usd
	us-gaap	Service Management Costs ServiceManagementCosts	15641000	usd
	us-gaap	Service Management Costs ServiceManagementCosts	16664000	usd
CY2017Q1	us-gaap	Service Management Costs ServiceManagementCosts	5122000	usd
CY2016Q1	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	1045000	usd
	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	3202000	usd
	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	3116000	usd
CY2017Q1	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	1122000	usd
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	395000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1105000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1243000	usd
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	332000	usd
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4063000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12617000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12125000	usd
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4483000	usd
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	14522000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	41782000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	42662000	usd
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	14006000	usd
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-876000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2844000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2091000	usd
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1222000	usd
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	3005000	usd
	us-gaap	Net Income Loss NetIncomeLoss	13713000	usd
	us-gaap	Net Income Loss NetIncomeLoss	9360000	usd
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	5900000	usd
CY2017Q1	us-gaap	Assets Net AssetsNet	91824000	usd
CY2016Q2	us-gaap	Assets Net AssetsNet	84888000	usd
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	18619000	usd
	us-gaap	Sales Revenue Net SalesRevenueNet	57146000	usd
	us-gaap	Sales Revenue Net SalesRevenueNet	54599000	usd
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	20008000	usd
CY2016Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	148000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1896000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	599000	usd
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	293000	usd
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	830000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2587000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2507000	usd
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	868000	usd
CY2016Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4097000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	15364000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	11937000	usd
CY2017Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	6003000	usd
CY2016Q1	us-gaap	Revenues Revenues	546000	usd
	us-gaap	Revenues Revenues	981000	usd
	us-gaap	Revenues Revenues	1594000	usd
CY2017Q1	us-gaap	Revenues Revenues	218000	usd
CY2016Q1	us-gaap	Profit Loss ProfitLoss	3881000	usd
	us-gaap	Profit Loss ProfitLoss	16557000	usd
	us-gaap	Profit Loss ProfitLoss	11451000	usd
CY2017Q1	us-gaap	Profit Loss ProfitLoss	7122000	usd
CY2017Q1	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	1406000	usd
CY2016Q2	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	1592000	usd
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12679000	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11757000	usd
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6920000	usd
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7719000	usd
CY2016Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2549000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	7015000	usd
CY2017Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1744000	usd
CY2016Q1	FONR	Net Revenues Derived From Nofault And Personal Injury Protection Claims NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims	.59	pure
	FONR	Net Revenues Derived From Nofault And Personal Injury Protection Claims NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.62	pure
	FONR	Net Revenues Derived From Nofault And Personal Injury Protection Claims NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.6	pure
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	6481000	usd
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	173702000	usd
CY2017Q1	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-19000	usd
CY2017Q1	FONR	Net Revenues Derived From Nofault And Personal Injury Protection Claims NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.62	pure
CY2016Q1	FONR	Net Revenues From Management And Other Fees Charged To Related Pcs NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs	-0.102	pure
	FONR	Net Revenues From Management And Other Fees Charged To Related Pcs NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs	-0.105	pure
	FONR	Net Revenues From Management And Other Fees Charged To Related Pcs NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs	-0.103	pure
CY2017Q1	FONR	Net Revenues From Management And Other Fees Charged To Related Pcs NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs	-0.11	pure
CY2017Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	2287000	usd
CY2017Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	2580000	usd
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	176761000	usd
CY2016Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-24000	usd
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	-675000	usd
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	-675000	usd
CY2017Q1	us-gaap	Stockholders Equity Attributable To Parent Not Allowable For Net Capital StockholdersEquityAttributableToParentNotAllowableForNetCapital	69157000	usd
CY2016Q2	us-gaap	Stockholders Equity Attributable To Parent Not Allowable For Net Capital StockholdersEquityAttributableToParentNotAllowableForNetCapital	52380000	usd
CY2017Q1	us-gaap	Minority Interest MinorityInterest	6268000	usd
CY2016Q2	us-gaap	Minority Interest MinorityInterest	8396000	usd
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	91824000	usd
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84888000	usd
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	128000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	128000	shares
	us-gaap	Interest Paid InterestPaid	147000	usd
	us-gaap	Interest Paid InterestPaid	280000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	740000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	235000	usd
CY2017Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	153000	usd
CY2016Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	392000	usd
CY2017Q1	FONR	Maximum Limit For Individual Claims Under Stoploss Umbrella Policy For Health Insurance MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance	100000	usd
CY2017Q1	FONR	Medical Receivable MedicalReceivable	11332000	usd
CY2016Q2	FONR	Medical Receivable MedicalReceivable	10127000	usd
CY2017Q1	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	18480000	usd
CY2016Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	15638000	usd
CY2017Q1	FONR	Accounts Receivable Net Related Party AccountsReceivableNetRelatedParty	30000	usd
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	75425000	usd
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	60776000	usd
CY2017Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	14942000	usd
CY2016Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13042000	usd
CY2017Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	482000	usd
CY2016Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	482000	usd
CY2017Q1	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	25000	usd
CY2016Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	207000	usd
CY2016Q1	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	8695000	usd
	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	26509000	usd
	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	24596000	usd
CY2017Q1	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	9028000	usd
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-145000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1293000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-235000	usd
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1140000	usd
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-778000	usd
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3698000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8310000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6003000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	5000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	6000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-4972000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-4138000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-3431000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-1871000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1896000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-599000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-122000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-65000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-1774000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-534000	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-17000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	178000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	249000	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-181000	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-427000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4008000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	576000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-72000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-437000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	223000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-143000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-278000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	9000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-596000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-43000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	12000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	17000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4476000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3674000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2587000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2507000	usd
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6050000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6143000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6050000	shares
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	545000	usd
CY2017Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2287000	usd
CY2016Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2402000	usd
CY2017Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	362000	usd
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6166000	shares
CY2017Q1	FONR	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	1031000	usd
CY2016Q2	FONR	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	894000	usd
CY2017Q1	FONR	Estimated Earnings EstimatedEarnings	999000	usd
CY2016Q2	FONR	Estimated Earnings EstimatedEarnings	491000	usd
CY2017Q1	FONR	Subtotal Costs Estimated Earnings And Billings On Uncompleted Contracts Plus Costs Incurred On Uncompleted Contracts SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts	2030000	usd
CY2016Q2	FONR	Subtotal Costs Estimated Earnings And Billings On Uncompleted Contracts Plus Costs Incurred On Uncompleted Contracts SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts	1385000	usd
CY2017Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	891000	usd
CY2016Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3189000	usd
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	245000	usd
CY2016Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	385000	usd
CY2017Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	123000	usd
CY2016Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	242000	usd
CY2017Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2580000	usd
CY2016Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2487000	usd
CY2017Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	797000	usd
CY2016Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1140000	usd
CY2016Q1	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-3830000	usd
	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-11859000	usd
	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-10608000	usd
CY2017Q1	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-3979000	usd
CY2017Q1	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	5255000	usd
CY2016Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	4064000	usd
CY2017Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	624000	usd
CY2016Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	-207000	usd
CY2017Q1	us-gaap	Other Liabilities OtherLiabilities	890000	usd
CY2016Q2	us-gaap	Other Liabilities OtherLiabilities	712000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9428000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10300000	usd
CY2017Q1	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	3614000	usd
CY2016Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	4370000	usd
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.5
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.55
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
	FONR	Provision For Bad Debts ProvisionForBadDebts	-38000	usd
	FONR	Provision For Bad Debts ProvisionForBadDebts	-300000	usd
CY2015Q3	FONR	Hmca Ownership Size Of Imperial Management Services Percent HmcaOwnershipSizeOfImperialManagementServicesPercent	0.242	pure
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4026000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15264000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11686000	usd
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5982000	usd
CY2016Q1	us-gaap	Investment Income Net InvestmentIncomeNet	56000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	145000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	164000	usd
CY2017Q1	us-gaap	Investment Income Net InvestmentIncomeNet	47000	usd
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7750000	usd
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8528000	usd
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9449000	usd
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13147000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2239000	usd
CY2017Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	279000	usd
CY2016Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	212000	usd
CY2017Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	2391000	usd
CY2016Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	1862000	usd
CY2017Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19599000	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19476000	usd
CY2015Q3	FONR	Ownership Interest After Reorganization For Health Management Corporation Of America Of Newly Expanded Hdm Percent OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent	0.458	pure
CY2015Q3	FONR	Ownership Interest After Reorganization For Hdm Original Investors Of Newly Expanded Hdm Percent OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent	0.3	pure
	dei	Entity Registrant Name EntityRegistrantName	Fonar Corporation
	dei	Entity Central Index Key EntityCentralIndexKey	0000355019
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	us-gaap	Interest Payable Current InterestPayableCurrent	45000	usd
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	45000	usd
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	4097000	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	15364000	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	11937000	usd
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	6002000	usd
CY2016Q1	us-gaap	Interest Expense InterestExpense	-127000	usd
	us-gaap	Interest Expense InterestExpense	-244000	usd
	us-gaap	Interest Expense InterestExpense	-416000	usd
CY2017Q1	us-gaap	Interest Expense InterestExpense	-69000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	usd
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2000	usd
CY2016Q1	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	4865000	usd
	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	14650000	usd
	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	13988000	usd
CY2017Q1	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	5049000	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	27000	usd
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106911000	usd
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-120624000	usd
CY2017Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	649000	usd
	FONR	Shares Of Common Stock Issued In Settlement Of Liabilities Shares. SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares.	107000	shares
	FONR	Value Of Shares Issued To Employees As Compensation Value. ValueOfSharesIssuedToEmployeesAsCompensationValue.	27000	usd
	FONR	Value Of Shares Issued In Settlement Of Liabilities Value. ValueOfSharesIssuedInSettlementOfLiabilitiesValue.	2239000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Reclassifications</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported consolidated net income for any periods presented.</font></p>
CY2016Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	145000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1293000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2017Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1140000	usd
CY2016Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	1900000	usd
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2017Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
	FONR	Proceeds Received From Acquisition Net ProceedsReceivedFromAcquisitionNet	88000	usd
	FONR	Included In Accompanying Condensed Consolidated Balance Sheets IncludedInAccompanyingCondensedConsolidatedBalanceSheets	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Included in the accompanying condensed consolidated balance sheets under the following captions:</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p> <p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts) (UNAUDITED)</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal; text-align: justify"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">June 30, 2016</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="width: 8%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">649</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 8%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">25</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">207</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">624</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">(207</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p>
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2	shares
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1900000	usd
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1000	shares
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	2000	usd
	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	200	shares
	FONR	Shares Of Common Stock Issued For Acquisition Shares SharesOfCommonStockIssuedForAcquisitionShares	42000	shares
	FONR	Value Of Shares Issued For Acquisition Value. ValueOfSharesIssuedForAcquisitionValue.	791000	usd
CY2017Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	110029000	usd
CY2016Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	800000	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
CY2017Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1900000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-649000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	403000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-182000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	112000	usd
CY2017Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	671000	usd
CY2017Q1	us-gaap	Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized	671000	usd
CY2017Q1	FONR	Stock Issued StockIssued	791000	usd
CY2017Q1	FONR	Additional Cash Considerationless Cash Received AdditionalCashConsiderationlessCashReceived	-120000	usd
CY2017Q1	FONR	Diagnostic Equipment DiagnosticEquipment	545000	usd
CY2017Q1	FONR	Leasehold Improvements LeaseholdImprovements	126000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000355019-17-000011-index-headers.html	Edgar Link	pending
0000355019-17-000011-index.html	Edgar Link	pending
0000355019-17-000011.txt	Edgar Link	pending
0000355019-17-000011-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fonar10-q_20170331.htm	Edgar Link	pending
fonar_exhibit-31.htm	Edgar Link	pending
fonar_exhibit-32.htm	Edgar Link	pending
fonr-20160930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
fonr-20160930_cal.xml	Edgar Link	unprocessable
fonr-20160930_def.xml	Edgar Link	unprocessable
fonr-20160930_pre.xml	Edgar Link	unprocessable
fonr-20160930.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fonr-20160930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FONR
FONAR CORP Stock $fonr

2017 Q1 Form 10-Q Financial Statement

#000035501917000011 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR FONAR CORP Stock $fonr

2017 Q1 Form 10-Q Financial Statement

#000035501917000011 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR
FONAR CORP Stock $fonr